Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 300 of 2228 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 08/31/06
End: -
Due: -
A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the Body
Phase: N/A
Priority: Normal
Start: 01/23/25
End: 03/27/25
Due: 03/27/26
Phase: N/A
Priority: Normal
Start: 09/17/18
End: 05/26/21
Due: 05/26/22
Phase: N/A
Priority: Normal
Start: 04/05/19
End: 09/02/19
Due: 09/02/20
Phase: N/A
Priority: Normal
Start: 01/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/31/98
End: 02/29/04
Due: 02/28/05
Phase: N/A
Priority: Normal
Start: 08/31/11
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/07/19
End: 05/14/20
Due: 05/14/21
Phase: N/A
Priority: Normal
Start: 05/31/11
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/14/21
End: 08/30/21
Due: 08/30/22
Phase: N/A
Priority: Normal
Start: 06/16/25
End: 10/12/28
Due: 10/12/29
Phase: N/A
Priority: Normal
Start: 06/25/25
End: 11/01/26
Due: 11/01/27
Phase: N/A
Priority: Normal
Start: 05/20/25
End: 02/22/29
Due: 02/22/30
Phase: N/A
Priority: Normal
Start: 06/30/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/10/17
End: 04/16/19
Due: 04/16/20
Phase: N/A
Priority: Normal
Start: 10/31/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 05/31/11
End: 08/31/13
Due: 08/31/14
Phase: N/A
Priority: Normal
Start: 10/17/17
End: 08/16/18
Due: 08/16/19
Phase: N/A
Priority: Normal
Start: 05/17/21
End: 11/30/21
Due: 11/30/22